↓ Skip to main content

MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer

Overview of attention for article published in Journal of Hematology & Oncology, July 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
patent
2 patents

Readers on

mendeley
261 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
Published in
Journal of Hematology & Oncology, July 2017
DOI 10.1186/s13045-017-0500-5
Pubmed ID
Authors

Veronica Tisato, Rebecca Voltan, Arianna Gonelli, Paola Secchiero, Giorgio Zauli

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 261 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 261 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 49 19%
Researcher 36 14%
Student > Bachelor 28 11%
Student > Master 23 9%
Student > Doctoral Student 18 7%
Other 35 13%
Unknown 72 28%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 56 21%
Medicine and Dentistry 41 16%
Chemistry 33 13%
Pharmacology, Toxicology and Pharmaceutical Science 18 7%
Agricultural and Biological Sciences 15 6%
Other 24 9%
Unknown 74 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 January 2023.
All research outputs
#1,728,927
of 23,556,846 outputs
Outputs from Journal of Hematology & Oncology
#113
of 1,218 outputs
Outputs of similar age
#35,157
of 314,960 outputs
Outputs of similar age from Journal of Hematology & Oncology
#3
of 30 outputs
Altmetric has tracked 23,556,846 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,218 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 314,960 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.